Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02756247
Title A Clinical Trial of Buparlisib and Ibrutinib in Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center

diffuse large B-cell lymphoma

follicular lymphoma

mantle cell lymphoma


Buparlisib + Ibrutinib

Age Groups: adult
Covered Countries USA

No variant requirements are available.